Covered recipient · General Payments record
THOMAS W COOPER
Allopathic & Osteopathic Physicians Dermatology
General Payments · PY2018–2023
$1,523.38
- Reported across 64 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $481.29 | 18 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $179.74 | 6 |
| PFIZER INC. | $82.30 | 3 |
| Incyte Corporation | $79.96 | 3 |
| E.R. Squibb & Sons, L.L.C. | $77.68 | 4 |
| Lilly USA, LLC | $61.61 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AbbVie Inc. | $31.93 | 04/04/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996514277 | CMS |
| AbbVie Inc. | $34.48 | 06/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996514281 | CMS |
| AbbVie Inc. | $32.54 | 07/11/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996514285 | CMS |
| AbbVie Inc. | $23.57 | 08/16/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996514289 | CMS |
| AbbVie Inc. | $23.22 | 09/05/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996514293 | CMS |
| AbbVie Inc. | $34.00 | 10/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996514297 | CMS |
| E.R. Squibb & Sons, L.L.C. | $26.22 | 04/11/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1015835923 | CMS |
| E.R. Squibb & Sons, L.L.C. | $16.44 | 05/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1015835927 | CMS |
| E.R. Squibb & Sons, L.L.C. | $18.33 | 11/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1015836109 | CMS |
| E.R. Squibb & Sons, L.L.C. | $16.69 | 11/29/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1015836113 | CMS |
| Incyte Corporation | $27.02 | 02/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1044409561 | CMS |
| Incyte Corporation | $25.12 | 06/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1044409697 | CMS |
| Incyte Corporation | $27.82 | 10/25/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1044409825 | CMS |
| Lilly USA, LLC | $34.13 | 09/27/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1032148995 | CMS |
| Lilly USA, LLC | $27.48 | 12/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1032321571 | CMS |
| PFIZER INC. | $30.36 | 03/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1049150503 | CMS |
| PFIZER INC. | $22.69 | 05/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1049151563 | CMS |
| PFIZER INC. | $29.25 | 08/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1050507523 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.